WallStreetZenWallStreetZen

NYSE: DNA
Ginkgo Bioworks Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ginkgo Bioworks Holdings earnings were -$472.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest DNA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$91.0M, down 15.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DNA reported annual earnings of -$547.0M, with -38.7% growth.

DNA earnings history

Current Revenue
$237.4M
Current Earnings
-$472.1M
Current Profit Margin
-198.8%

DNA Return on Equity

Current Company
-63.1%
Current Industry
-60.2%
Current Market
31.3%
DNA's Return on Equity (-63.1%)... subscribe to Premium to read more.
High Return on Equity Performance

DNA undefined

Current Company
-32.7%
Current Industry
-2.5%
DNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DNA announces earnings.

DNA undefined

Current Company
-40.11%
Current Industry
5.8%
DNA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DNA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DNA-$377.05M-$472.08MN/A-$9.12
REPL-$235.43M-$247.30MN/A-$3.07
VIR-$561.22M-$577.65MN/A-$4.22
GYRE$13.36M$7.25M-89.29%$0.08
IMNM-$202.55M-$205.11MN/A-$3.18
View Top Biotech Stocks

Ginkgo Bioworks Holdings Earnings Reports & History FAQ

What were Ginkgo Bioworks Holdings's earnings last quarter?

On DNA's earnings call on Invalid Date, Ginkgo Bioworks Holdings (NYSE: DNA) reported Q1 2025 earnings per share (EPS) of -$1.68, up 49.24% year over year. Total DNA earnings for the quarter were -$90.96 million. In the same quarter last year, Ginkgo Bioworks Holdings's earnings per share (EPS) was -$3.31.

If you're new to stock investing, here's how to buy Ginkgo Bioworks Holdings stock.

Is Ginkgo Bioworks Holdings profitable or losing money?

As of the last Ginkgo Bioworks Holdings earnings report, Ginkgo Bioworks Holdings is currently losing money. Ginkgo Bioworks Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$472.08 million, a 44.71% decrease year over year.

What was DNA's earnings growth in the past year?

As of Ginkgo Bioworks Holdings's earnings date in Invalid Date, Ginkgo Bioworks Holdings's earnings has grown year over year. DNA earnings in the past year totalled -$472.08 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.